Emergent BioSolutions (EBS) Misses Q1 EPS by 65c
Tweet
Share
E-mailGet Alerts EBS Hot Sheet
Price: $6.46 +3.86%
EPS Growth %: -138.7%
Financial Fact:
Research and development: 27.19M
Today's EPS Names:
RCBC, GASS, YSG, More
EPS Growth %: -138.7%
Financial Fact:
Research and development: 27.19M
Today's EPS Names:
RCBC, GASS, YSG, More
Join SI Premium – FREE
Emergent BioSolutions (NYSE: EBS) reported Q1 EPS of $0.21, $0.65 worse than the analyst estimate of $0.86. Revenue for the quarter came in at $156.1 million versus the consensus estimate of $205 million.
For earnings history and earnings-related data on Emergent BioSolutions (EBS) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- PVH Corp. (PVH) Tops Q2 EPS by 62c, Beats on Revenue; Offers FY27 EPS Guidance
- Destination XL Group names Jimmy Olsson as chief growth officer
- Tilly's, Inc. (TLYS) Tops Q2 EPS by 10c, Beats on Revenue
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
